BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25805005)

  • 1. Factors impacting survival in children with renal cell carcinoma.
    Rialon KL; Gulack BC; Englum BR; Routh JC; Rice HE
    J Pediatr Surg; 2015 Jun; 50(6):1014-8. PubMed ID: 25805005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
    Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
    World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 study.
    Geller JI; Cost NG; Chi YY; Tornwall B; Cajaiba M; Perlman EJ; Kim Y; Mullen EA; Glick RD; Khanna G; Daw NC; Ehrlich P; Fernandez CV; Dome JS;
    Cancer; 2020 Dec; 126(23):5156-5164. PubMed ID: 32926409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal cell carcinoma: assessment of key pathologic prognostic parameters and patient characteristics in 47,909 cases using the National Cancer Data Base.
    Nese N; Paner GP; Mallin K; Ritchey J; Stewart A; Amin MB
    Ann Diagn Pathol; 2009 Feb; 13(1):1-8. PubMed ID: 19118775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment trends, determinants, and survival of partial and radical nephrectomy for stage I renal cell carcinoma: results from the National Cancer Data Base, 2004-2013.
    Plante K; Stewart TM; Wang D; Bratslavsky G; Formica M
    Int Urol Nephrol; 2017 Aug; 49(8):1375-1381. PubMed ID: 28550475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
    Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
    Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
    Itano NB; Blute ML; Spotts B; Zincke H
    J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis.
    O'Malley RL; Hayn MH; Brewer KA; Underwood W; Hellenthal NJ; Kim HL; Sorokin I; Schwaab T
    World J Urol; 2015 Nov; 33(11):1807-14. PubMed ID: 25805189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can partial nephrectomy provide equal oncological efficiency and safety compared with radical nephrectomy in patients with renal cell carcinoma (≥4cm)? A propensity score-matched study.
    Lee H; Oh JJ; Byun SS; Jeong CW; Kwak C; Jeong BC; Jeon SS; Lee HM; Choi HY; Seo SI
    Urol Oncol; 2017 Jun; 35(6):379-385. PubMed ID: 28284894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
    Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
    Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney size and cancer-specific survival for patients undergoing nephrectomy for pT1 clear cell renal cell carcinoma.
    Jorns JJ; Thiel DD; Lohse C; Williams A; Arnold M; Cheville J; Leibovich B; Parker AS
    Urology; 2012 Jul; 80(1):147-50. PubMed ID: 22748870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors related to lymph node sampling at the time of surgery in children, adolescents, and young adults with unilateral non-metastatic renal cell carcinoma.
    Saltzman AF; Stokes W; Walker J; Cost NG
    J Pediatr Urol; 2019 May; 15(3):259.e1-259.e7. PubMed ID: 30819622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic versus open partial nephrectomy for the treatment of pathological T1N0M0 renal cell carcinoma: a 5-year survival rate.
    Permpongkosol S; Bagga HS; Romero FR; Sroka M; Jarrett TW; Kavoussi LR
    J Urol; 2006 Nov; 176(5):1984-8; discussion 1988-9. PubMed ID: 17070227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection.
    Gershman B; Moreira DM; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
    Eur Urol; 2017 Aug; 72(2):300-306. PubMed ID: 28094055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival rates after resection for locally advanced kidney cancer: Memorial Sloan Kettering Cancer Center 1989 to 2012 experience.
    Bazzi WM; Sjoberg DD; Feuerstein MA; Maschino A; Verma S; Bernstein M; O'Brien MF; Jang T; Lowrance W; Motzer RJ; Russo P
    J Urol; 2015 Jun; 193(6):1911-6. PubMed ID: 25524244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes following partial nephrectomy by tumor size.
    Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
    J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
    Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system.
    Belldegrun A; Tsui KH; deKernion JB; Smith RB
    J Clin Oncol; 1999 Sep; 17(9):2868-75. PubMed ID: 10561364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 10-year oncologic outcomes after laparoscopic and open partial nephrectomy.
    Lane BR; Campbell SC; Gill IS
    J Urol; 2013 Jul; 190(1):44-9. PubMed ID: 23306087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.